Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Stephanie Everts"'
Autor:
Thomas Hawthorne, David M. Barris, Jonathan Gill, David S. Geller, Stephanie Everts, Peter J. Houghton, Michael Roth, Richard Gorlick, E. Anders Kolb, Vicky Kuo, Sajida Piperdi
Publikováno v:
Pediatric Blood & Cancer. 63:32-38
Background Cure rates for children and young adults with osteosarcoma have remained stagnant over the past three decades. Targeting glycoprotein non-metastatic b (GPNMB) with the antibody-drug conjugate glembatumumab vedotin has improved outcomes for
Autor:
Stephanie Everts, Nikolaos I. Kyratsous, Ingo Bartholomäus, Guokun Zhang, Marija Pesic, Joanna M. Watt, Naoto Kawakami, Miriam Wörner, Ping Fang, Reinhard Hohlfeld, H. Wekerle, Marsilius Mues, Joachim W. Ellwart, Isabel J. Bauer, Barry V. L. Potter
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Proc. Natl. Acad. Sci. U.S.A. 114, E6381-E6389 (2017)
Proc. Natl. Acad. Sci. U.S.A. 114, E6381-E6389 (2017)
In experimental autoimmune encephalitis (EAE), autoimmune T cells are activated in the periphery before they home to the CNS. On their way, the T cells pass through a series of different cellular milieus where they receive signals that instruct them
Autor:
Ying Jun Cao, Rahul P. Bakshi, Edward J. Fuchs, Craig W. Hendrix, Jean Anderson, Stephanie Everts, Steven R. Tannenbaum, Nicolette A. Louissaint, Rosa G. Liberman, Paul L. Skipper, Sridhar Nimmagadda
Publikováno v:
AIDS Research and Human Retroviruses. 29:1443-1450
HIV seroconversion outcomes in preexposure prophylaxis (PrEP) trials of oral tenofovir (TFV)-containing regimens are highly sensitive to drug concentration, yet less-than-daily dosing regimens are under study. Description of TFV and its active moiety
Autor:
Ivy Song, Amanda Peppercorn, Elizabeth Purdy, Shuguang Chen, Stephen C. Piscitelli, Kelly E. Dooley, Charles Flexner, Julie Borland, Patrick Sayre, Stephanie Everts
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 62:21-27
Background Cotreatment of tuberculosis (TB) and HIV among coinfected patients is now the standard of care. Rifampin (RIF) is a standard part of TB treatment but is a potent inducer of drug metabolizing enzymes. This study evaluated the effect of RIF
Autor:
Michael, Roth, David M, Barris, Sajida, Piperdi, Vicky, Kuo, Stephanie, Everts, David, Geller, Peter, Houghton, E Anders, Kolb, Thomas, Hawthorne, Jonathan, Gill, Richard, Gorlick
Publikováno v:
Pediatric bloodcancer. 63(1)
Cure rates for children and young adults with osteosarcoma have remained stagnant over the past three decades. Targeting glycoprotein non-metastatic b (GPNMB) with the antibody-drug conjugate glembatumumab vedotin has improved outcomes for patients w
Autor:
Priscilla Chee, Gary Calandra, Craig W. Hendrix, Myaing M. Nyunt, Ron MacFarland, Stephanie Everts, Stephen Becker, Robert J. Scarborough
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 47(5)
Background: Many antiretroviral drugs used in HIV care involve complex drug metabolism by CYP3A4 and CYP2D6 enzymes, and drug interactions are problematic clinically. AMD070, a novel entry inhibitor, is an inhibitor of X4-tropic HIV virus. In vitro d